• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Does the antitumoral activity of platinum (IV) derivatives result from their in vivo reduction?

作者信息

Rotondo E, Fimiani V, Cavallaro A, Ainis T

出版信息

Tumori. 1983 Feb 28;69(1):31-6. doi: 10.1177/030089168306900105.

DOI:10.1177/030089168306900105
PMID:6836747
Abstract

The antitumoral activity of some octahedral platinum(IV) and square-planar platinum(II) derivatives against Yoshida ascites tumor in the rat is reported. It is shown that only those octahedral platinum(IV) complexes which give active reduction products are active. These results support the hypothesis that the antitumor activity of octahedral complexes involves activation by in vivo reduction. Anticancer drugs functioning by this mechanism may be preferentially toxic to or may localize in hypoxic areas of tumors.

摘要

相似文献

1
Does the antitumoral activity of platinum (IV) derivatives result from their in vivo reduction?
Tumori. 1983 Feb 28;69(1):31-6. doi: 10.1177/030089168306900105.
2
Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.铂(IV)配合物与查耳酮类似物缀合物作为双重靶向抗癌剂:体外和体内研究。
Bioorg Chem. 2020 Dec;105:104430. doi: 10.1016/j.bioorg.2020.104430. Epub 2020 Oct 27.
3
Relationship between topological properties and biological activity of platinum (II) complexes.铂(II)配合物的拓扑性质与生物活性之间的关系。
Arch Immunol Ther Exp (Warsz). 1991;39(1-2):75-84.
4
Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.莫替沙芬钆激活铂(IV)前药作为一种氧化还原介体。
Angew Chem Int Ed Engl. 2016 Oct 4;55(41):12626-31. doi: 10.1002/anie.201604236. Epub 2016 Jul 5.
5
Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin.
Jpn J Cancer Res. 1985 Jan;76(1):68-74.
6
Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo.烟酰胺配位的铂(IV)-钌(II)嵌合配合物在体内具有协同抑制肿瘤转移和生长的作用,同时潜在降低毒性。
Chem Commun (Camb). 2020 Mar 10;56(20):3069-3072. doi: 10.1039/c9cc09016a.
7
Structure-antitumour activity relationships for new platinum complexes.新型铂配合物的结构-抗肿瘤活性关系
Chem Biol Interact. 1982 Nov;42(2):153-64. doi: 10.1016/0009-2797(82)90129-6.
8
In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors.顺铂敏感和耐药大鼠卵巢肿瘤中铂、钛和钌金属配合物的体外评估
Cancer Chemother Pharmacol. 1991;27(4):301-7. doi: 10.1007/BF00685116.
9
Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.一系列反式铂抗肿瘤配合物的合成及其体内外抗肿瘤活性
J Med Chem. 1995 Aug 4;38(16):3016-24. doi: 10.1021/jm00016a004.
10
Interactions of platinum metals and their complexes in biological systems.铂金属及其配合物在生物系统中的相互作用。
Environ Health Perspect. 1975 Apr;10:73-83. doi: 10.1289/ehp.751073.

引用本文的文献

1
Unusual DNA binding modes for metal anticancer complexes.金属抗癌配合物的异常DNA结合模式。
Biochimie. 2009 Oct;91(10):1198-211. doi: 10.1016/j.biochi.2009.03.017. Epub 2009 Apr 1.
2
Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.谷胱甘肽还原抗癌活性四氯氨(亚)铂(IV)化合物的动力学及机制
J Biol Inorg Chem. 2000 Jun;5(3):300-6. doi: 10.1007/pl00010658.
3
Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogues.铂类癌症化疗的进展。顺铂类似物设计的进展。
Cancer Metastasis Rev. 1988 Apr;7(1):67-89. doi: 10.1007/BF00048279.
4
Studies on the human metabolism of iproplatin.
Cancer Chemother Pharmacol. 1989;25(1):10-4. doi: 10.1007/BF00694331.